changes in endothelial, macrophage, and smooth muscle cells functions. Therefore, improving dyslipidemia would be eff ective to prevent complications of diabetic patients. [8] Several treatments including consumption of herbal medicines, [9] soy protein, [10] w-3 fa y acids, [11] and fi ber [12] have been suggested to improve dyslipidemia in diabetic patients. It is suggested that consumption of probiotics would be a novel approach to reduce the elevated levels of cholesterol. [13] Probiotics are defi ned as live microorganisms which have benefi cial health effects on their host, when enter the intestine with an adequate amount. [14] Some of these health eff ects include: lowering hypercholesterolemia, [15] prevention or management of diarrhea, constipation, lactose intolerance, diabetes mellitus, [16] and colon cancer [17] Two main groups of probiotic bacteria, which are most commonly used, involve Lactobacilli and Bifi dobacteria. [18] Some studies indicated that probiotics may be able to prevent increased levels of total cholesterol (TC), LDL-c and balance the ratio of LDL-c/HDL-c by deconjugating of bile, hydrolysis of bile salts and increase
INTRODUCTION
Diabetes mellitus is one of the main endocrine diseases, which is more prevalent in the worldwide. [1] Cardiovascular disease, as one of several chronic disorders, is the major complication of type 2 diabetes mellitus (T2DM). Cardio-vascular disease may result from associated abnormalities of plasma lipid and lipoprotein metabolism. [2] Alteration in plasma lipid and lipoprotein profi le has been documented in diabetic patients. [3] There are some reports in literature suggesting that the insulin resistance has a central role in the development of dyslipidemia in diabetic patients. [4] [5] [6] In insulin resistance status, free fa y acids fl ux from adipose tissue to liver and subsequently increase synthesis of very low density lipoprotein cholesterol and low density lipoprotein cholesterol (LDL-c) and decrease high density lipoprotein cholesterol (HDL-c) levels. [7] Moreover, hyperglycemia in insulin resistance can lead to increase of advanced glycation end products density. These products may directly promote atherosclerosis through cholesterol absorption, which consequently prevent and reduce the prevalence of cardio-vascular disease. [19] Consumption of probiotics in healthy men increased in serum levels of HDL-c and reduced in LDL-c/HDL-c indices. [20] Decreased serum LDL-c levels have been reported in hyper-lipidemic subjects by probiotic. [21] Nevertheless, intake of Lactobacillus rhamnosus and Propionibacterium freudenreichii in hypercholesterolemia volunteers had no aff ect on lipid profi le. [22] As was mentioned, available evidences about the eff ects of probiotic bacteria on lipid profi le are controversial. [20] [21] [22] Therefore, this study with diff erent type of probiotic bacteria was designed to evaluate the hypocholestrolemic eff ect of probiotic yogurt on lipid profi le in patients with type 2 diabetes.
MATERIALS AND METHODS

Subjects
This study was conducted in 44 patients with T2DM were participated in this double-blind, randomized controlled clinical trial. This 8 weeks clinical trial was conducted from December 2011 to February 2012. The inclusion criteria included males and females, body mass index (BMI) >25, serum LDL-c level of ≥100 mg/dl (normal range for men and women <100 mg/dl). Exclusion criteria included: insulin injection; any changes in using medication; smoking; lactose intolerance; thyroid dysfunction; chronic infl ammatory diseases; cardio-vascular disease; renal dysfunction; pregnancy; breast feeding; and having any weight loose or weight gain regimes. The sample size was determined based on the primary information obtained from the study by Oze et al. for LDL-c. [20] For an α value equal to 0.05 and a power of 80%, the sample size was computed as 15 per group. This number was increased to 22 per group to accommodate the anticipated dropout rate. The study was approved by the Research Ethic Commi ee of Ahvaz Jundishapur University of Medical Sciences, Iran (NRC -9008). A wri en consent was obtained from all subjects.
All subjects were allocated into two groups using blocked randomization. For the subjects in the intervention group 300 g probiotic yogurt containing 3.7 × 10 6 cfu/mg of both Lactobacillus acidophilus La-5 and Bifidobacterium lactis Bb-12 (Chr. Hansen, Hoersholm, Denmark) was provided to consume every day for 8 weeks. On the other hand, the control group received 300 g/d conventional yogurt containing Lactobacillus bulgaricus and Streptococcus thermophiles for 8 weeks. The mean of the components of probiotic and conventional yogurt per 100 g is presented in Table 1 . Both types of yogurts had a similar taste, appearance and specially prepared for this study by Pegah Dairy Industries Co. (Ahvaz, Iran). The patients were instructed to eat yogurt twice a day by lunch and dinner. [23] All subjects were asked to maintain their normal lifestyle, physical activity and eating habits and avoid consuming other probiotic and fermented products during the study. They also were asked to keep yogurts in the refrigerator at a temperature of below 4°C. Yogurts were freshly produced and provided to subjects weekly. The compliance with the yogurt consumption of all subjects was assessed twice a week by telephone interviews.
Anthropometric indices, dietary intakes and biochemical indices were evaluated in all subjects before and a er intervention. Physical activity level was also evaluated and classifi ed into low, moderate and vigorous levels. [24] In this study, dietary intake of subjects was assessed by 3-day diet records and Nutritionist IV program was used to estimate dietary intake of patients. The body fat mass of subjects were also measured by body state set (QuadScan 4000).
A volume of 10 ml blood sample was collected and sera were separated, processed and stored at −80°C until analysis. Serum TC, triglycerides (TG) and HDL-c were measured enzymatically with Parsazmun's kits (DiaSys, Germany). LDL-c level was measured by Friedewald formula as follow:
LDL-c = TC -HDL-c − (triglyceride/5).
Statistical analyses
Statistical analyses were carried out using the Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, USA) Program version 17 for windows. All data were expressed as mean ± standard deviation Independent-sample t-test, paired sample t-test, ANCOVA and repeated measures were used for statistical analysis. P < 0.05 were considered to be signifi cant.
RESULT
In the current study, 42 patients a ended randomization and blood collection. Thus, 21 subjects were randomly assigned to each group. Patients did not report any adverse eff ect during the study related to yogurt consumption and both yogurts were well-tolerated. The mean age of subjects was 51 years. 26.19% (11 patients) of the study population was male and 73.80% (31 patients) was female. Regarding with the classifi cation of physical activity level, 54.76%, 42.85, and 2.38% of the study population had low, moderate and vigorous physical activity level, respectively. However, there were not signifi cant diff erences between two groups regarding with physical activity (P > 0.05).
Anthropometric characteristics of subjects at baseline and postintervention were shown in Table 2 . For anthropometric parameters, no signifi cant diff erences were seen between intervention and control groups at baseline and postintervention (P > 0.05).
Regarding with dietary intake analysis, the diff erences in mean energy and nutrient intake were not signifi cant (P > 0.05) between two groups at baseline. Calcium intake was increased in both groups after conventional and probiotic yogurt consumption, but not signifi cantly (P = 0.061 and P = 0.057, respectively). Protein intake was signifi cantly (P = 0.008) elevated in control group at the end of study. However, the intakes of other nutrients did not signifi cantly change from baseline to the postintervention in both groups [ Table 3 ].
In this study, the levels of HbA1c were signifi cantly reduced in the intervention group compared with the control group at the end of study (7.09 ± 1.23 vs. 8.09 ± 1.58, P = 0.038). A er adjusting for confounding factors (age, gender, physical activity, waist to hip ratio, and energy intake), the eff ects of probiotic and conventional yogurt consumption on lipid profi le in patients with T2DM have been shown in Table 4 . There were no signifi cant diff erences found between two groups regarding with serum TC, TG, HDL-c and LDL-c at baseline. Serum levels of LDL-c were decreased in subjects in the intervention group post probiotic consumption, but not signifi cantly (P = 0.059). Moreover, the LDL-c/HDL-c ratio was signifi cantly reduced in the intervention group compared with the control group at the end of study. HDL-c levels were also signifi cantly higher in the intervention group than in the control group postintervention (P = 0.023). However, no signifi cant diff erences were observed in TC and TG levels between two groups at the end of study (P = 0.104 and P = 0.108 respectively). In the intervention group the levels of TC were signifi cantly lowered postintervention (P = 0.044). Serum levels of TG were also diminished in the intervention group, but not signifi cantly (P = 0.18).
DISCUSSION
Diabetes mellitus is an endocrine disorder that characterized by hyperglycemia [25] and associated with disorders in lipid metabolism. [26] Dyslipidemia is a major risk factor for cardio-vascular disease in patients with diabetes.
[27] Some human and animal studies suggested that using probiotic may reduce serum lipid levels. [28, 29] Therefore, this study was carried out to evaluate probiotic eff ects on lipid profi le in patients with T2DM. In the present study, none of the subjects reported any adverse eff ect during the study related to yogurt consumption and it was reported that both kinds of yogurts were well-tolerated, therefore it is suggested that the compliance rate was satisfi ed. There were no signifi cant diff erences observed in dietary intake, anthropometric indices and physical activity level between probiotic and conventional consumers during the study. Hence, it is suggested that these possible confounders did not aff ect on the results of lipid profi les in this study. In another study, Sadrzadeh-Yeganeh et al. indicated that use of L. acidophilus La-5 and B. lactis Bb-12 didn't signifi cant changes anthropometry indices in hypercholestrolemic patients. [30] Results of the study by Fuentes et al. also indicated that 12 weeks consumption of Lactobacillus plantarum has no eff ect on weight, BMI, body fat mass in hyper-cholesterolemic subjects. [31] In other experiments shown that body weight and weight of liver were not aff ected by B. lactis Bb-12 in wild type mice. [32] In this study, it was shown that consumption of probiotic yogurt signifi cantly reduced HbA1c levels. The results also showed that consumption of probiotic yogurt signifi cantly reduced serum levels of LDL-c and LDL-c/HDL-c ratio, in patients with T2DM patients. Moreover, serum HDL-c levels were signifi cantly increased a er consumption of probiotic yogurt. These results concur with other studies. Ejtahed et al. found that consumption of probiotic yogurt in T2DM patients signifi cantly reduced HbA1c concentration and serum levels of LDL-c and LDL-c/HDL-c ratio. [33] Decreased serum levels of LDL-c by Lactobacillus reuteri NCIBM30242 have been also reported by Jones et al. [34] In a study by Wang et al., it was indicated that Lactobacillus LIP-1 and MG9-2 signifi cantly decreased serum level of TG, TC and LDL-c in high-lipid diet fed mice. [35] Baroutkoub et al. found that L. acidophilus and B. lactis signifi cantly reduced LDL-c and TC level in hypercholestrolemic patients. [19] Consumption of a new symbiotic shake containing L. acidophilus, B. bifi dum and fructo-oligosaccharides in older with type 2 diabetic patients signifi cantly increased serum HDL-c, but did not impact on TC and TG in Moroti et al. Study.
[36] Improvement of LDL-c/HDL-c ratio and increased serum level of HDL-c by probiotic have been reported in Kiessling et al. trial. [37] In another study, Fabian and Elmadfa found that daily consumption of probiotic yogurt signifi cantly raised serum HDL-c and improved ratio of LDL-c/HDL-c. [38] However, there are some other studies in contrast with our study regarding with the above-mentioned results. Asemi et al. showed that eating probiotic yogurt did not change lipid profi le in pregnant women. [39] Sadrzadeh-Yeganeh et al. also reported similar results in women. [29] Moreover, Ha aka et al. indicated that intake of L. rhamnosus LC705 did not aff ect blood lipids in hyperlipidemic men. [22] 0.833 0.002 -SD = Standard deviation; WHR = Waist to hip ratio; TC = Total cholesterol; LDL-C = Low density lipoprotein-cholesterol; HDL-C = High density lipoprotein-cholesterol; TG = Triglyceride; P a = P value between two groups at baseline and postintervention after adjusting for age, gender, physical activity, WHR and energy intake (ANCOVA); P b = P value within two groups from baseline to postintervention after adjusting for WHR change and energy intake change (repeated measure ANCOVA)
There are several possible mechanisms suggested about the eff ects of probiotic bacteria on lipid profi le. It is indicated that diff erent bacteria species may have diff erent abilities to aff ect lipid profi le. [29, 40] Lee do et al. showed that short chain fatty acids that are produced by lactic acid bacteria could inhibit the enzymatic synthesis of cholesterol. [40] Probiotic bacteria may also facilitate excreting of cholesterol through feces. [36] Furthermore, these bacteria can assimilate cholesterol and lead to its reduction. Moreover, it is suggested that lactic acid bacteria may bind with cholesterol and inhibit its reabsorption in the body. [41] In addition, Lactobacilli and Bifi dobacteria cells are able to hydrolyze conjugated bile acids, excrete them faster and reduce its level to which they can be absorbed. [42, 43] The findings of this study also suggested that probiotic yogurt consumption might not aff ect on serum TC and TG levels in patients with T2DM due to some possibilities that we suggest the type of microorganism used and some limitations of study including the number of subjects and short period of intervention in this study.
CONCLUSION
This study indicated that consuming probiotic yogurt can improve lipid abnormalities in patients with T2DM. Therefore, it is suggested that eating probiotic yogurt may be used as an alternative prevention approach and treatment method to reduce diabetic complications. We also suggest further studies with larger sample size, longer period of intervention and various type of probiotic.
